Opportunity Information: Apply for PA 19 047

The National Institutes of Health (NIH) funding opportunity titled "Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional)" (Funding Opportunity Number: PA-19-047; CFDA: 93.173) supports Research Project Grant (R01) applications focused on improving what we know about how to evaluate and treat people with severe speech and physical impairments (SSPI). The core goal is to advance rigorous research that strengthens the evidence base behind AAC tools, systems, and intervention strategies, with an emphasis on real-world communication challenges. AAC is broadly defined here as the set of tools and strategies individuals use to communicate when natural speech is not sufficient, and the opportunity highlights the large global population that relies on AAC to participate in daily life at home, in school, at work, and in the community.

This announcement is specifically limited to the R01 mechanism, which typically funds substantial, multi-year research projects, and it allows (but does not require) clinical trials, meaning applicants can propose studies that range from non-clinical foundational work through to human intervention research. The FOA explicitly welcomes a wide research scope, including basic research (for example, studies that build foundational knowledge about communication processes or AAC user needs), clinical research (for example, testing assessment approaches or interventions with AAC users), and translational research (for example, moving promising methods or technologies into practical, scalable clinical or educational use). In practical terms, it is designed to support projects that can meaningfully improve how AAC is selected, customized, taught, evaluated, and implemented for individuals with SSPI.

Eligibility is broad and includes many types of organizations that could reasonably conduct AAC research. Eligible applicants include federal, state, county, and local government entities; special districts; independent school districts; public and private institutions of higher education; and a wide range of nonprofit and for-profit organizations (excluding small business restrictions since both small businesses and other for-profits are listed as eligible). It also includes Native American tribal governments (federally recognized) and Native American tribal organizations (including those other than federally recognized tribal governments), along with public housing authorities/Indian housing authorities. In addition, the announcement calls out other eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Faith-based and community-based organizations may apply, as can regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations), which signals an intent to encourage broad participation and potentially diverse populations, settings, and perspectives.

Administratively, this is a discretionary grant in the health funding category, issued by NIH. The source information lists an original closing date of January 7, 2022, and does not specify an award ceiling or expected number of awards in the provided excerpt, which usually means applicants should rely on the full FOA and NIH institute guidance for budget expectations, paylines, and submission cycles. Overall, the opportunity is aimed at strengthening AAC science from multiple angles, with the practical endpoint of improving communication outcomes and quality of life for people who cannot rely on natural speech and who face significant speech and physical challenges.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173.
  • This funding opportunity was created on 2018-10-31.
  • Applicants must submit their applications by 2022-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 19 047

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQ)

What is the title of this NIH funding opportunity?

The funding opportunity is titled "Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional)."

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is PA-19-047.

What CFDA number is associated with this opportunity?

The CFDA number listed for this opportunity is 93.173.

Which agency is offering this grant?

This is a National Institutes of Health (NIH) discretionary grant in the health funding category.

What type of grant mechanism does this announcement support?

This announcement is specifically limited to the Research Project Grant (R01) mechanism, which typically supports substantial, multi-year research projects.

What is the main purpose or goal of this funding opportunity?

The core goal is to advance rigorous research that strengthens the evidence base behind AAC tools, systems, and intervention strategies, with a strong emphasis on real-world communication challenges for individuals with severe speech and physical impairments (SSPI).

Who is the intended population that the research should benefit?

The opportunity focuses on people with severe speech and physical impairments (SSPI), especially individuals who cannot rely on natural speech and use AAC to participate in daily life at home, in school, at work, and in the community.

How does this opportunity define Augmentative and Alternative Communication (AAC)?

AAC is broadly defined as the set of tools and strategies individuals use to communicate when natural speech is not sufficient.

What kinds of research does the FOA welcome?

The announcement welcomes a wide scope of research, including basic research, clinical research, and translational research related to AAC for individuals with SSPI.

What are examples of basic research topics that could fit this FOA?

Examples mentioned include studies that build foundational knowledge about communication processes or AAC user needs.

What are examples of clinical research topics that could fit this FOA?

Examples mentioned include testing assessment approaches or interventions with AAC users.

What are examples of translational research topics that could fit this FOA?

Examples mentioned include moving promising methods or technologies into practical, scalable clinical or educational use.

Does this funding opportunity allow clinical trials?

Yes. Clinical trials are optional under this FOA, meaning applicants may propose a clinical trial but are not required to do so.

Is the FOA limited only to human intervention studies?

No. Because clinical trials are optional and the FOA welcomes basic, clinical, and translational work, the supported study designs can range from non-clinical foundational research through human intervention research.

What kinds of AAC-related outcomes or improvements is NIH trying to support through this FOA?

The FOA is designed to support projects that meaningfully improve how AAC is selected, customized, taught, evaluated, and implemented for individuals with SSPI.

Why does the FOA emphasize "real-world communication challenges"?

Based on the description provided, the FOA places emphasis on research that addresses practical communication needs in everyday environments such as home, school, work, and community settings.

Who is eligible to apply?

Eligibility is broad and includes many types of organizations capable of conducting AAC research, spanning government entities, education institutions, nonprofits, and for-profits, as well as tribal entities and other specifically named institution types.

Are government entities eligible to apply?

Yes. Eligible applicants include federal, state, county, and local government entities, as well as special districts and independent school districts.

Are colleges and universities eligible to apply?

Yes. Public and private institutions of higher education are eligible.

Are nonprofit organizations eligible to apply?

Yes. A wide range of nonprofit organizations are listed as eligible applicants.

Are for-profit organizations eligible to apply?

Yes. For-profit organizations are included among eligible applicants, and the eligibility list explicitly includes both small businesses and other for-profit entities.

Are tribal governments and tribal organizations eligible to apply?

Yes. Native American tribal governments (federally recognized) are eligible, and Native American tribal organizations (including those other than federally recognized tribal governments) are also listed as eligible.

Are U.S. territories or possessions eligible to apply?

Yes. U.S. territories or possessions are listed as eligible.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. Non-U.S. entities (foreign organizations) are included as eligible applicants, indicating that foreign organizations may apply.

Are faith-based or community-based organizations eligible to apply?

Yes. The opportunity states that faith-based and community-based organizations may apply.

Are public housing authorities eligible to apply?

Yes. Public housing authorities/Indian housing authorities are included in the eligibility list.

Does the FOA encourage applications from specific institution types (for example, MSIs)?

Yes. The eligibility list calls out multiple institution categories, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

Does the provided excerpt specify an award ceiling (maximum award amount)?

No. The excerpt provided states that it does not specify an award ceiling.

Does the provided excerpt specify the expected number of awards?

No. The excerpt provided states that it does not specify the expected number of awards.

What is the closing date shown in the provided information?

The source information lists an original closing date of January 7, 2022.

If the excerpt does not list budget expectations or number of awards, where would applicants typically look?

The provided description indicates that applicants should rely on the full FOA and NIH institute guidance for budget expectations, paylines, and submission cycles.

What is the broader impact this opportunity is aiming for?

Overall, the opportunity aims to strengthen AAC science from multiple angles, with a practical endpoint of improving communication outcomes and quality of life for individuals who cannot rely on natural speech and who face significant speech and physical challenges.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed)

Previous opportunity: FY 2019 Land Buy-Back Program for Tribal Nations

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 19 047

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 19 047) also looked into and applied for these:

Funding Opportunity
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) Apply for PAR 19 048

Funding Number: PAR 19 048
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed) Apply for PA 19 049

Funding Number: PA 19 049
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Sustainable Access for Expanded Voluntary Medical Male circumcision (VMMC) Services (SAFE) Apply for SOURCES SOUGHT NOTICE 2018

Funding Number: SOURCES SOUGHT NOTICE 2018
Agency: Tanzania USAID-Dar es Salaam
Category: Health
Funding Amount: Case Dependent
Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) Apply for RFA AG 20 004

Funding Number: RFA AG 20 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed) Apply for PAR 19 061

Funding Number: PAR 19 061
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) Apply for PA 19 067

Funding Number: PA 19 067
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 053

Funding Number: RFA AI 18 053
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,999
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) Apply for PA 19 066

Funding Number: PA 19 066
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) Apply for PA 19 068

Funding Number: PA 19 068
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed) Apply for RFA DE 19 008

Funding Number: RFA DE 19 008
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed) Apply for RFA DE 19 009

Funding Number: RFA DE 19 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional) Apply for RFA AA 19 005

Funding Number: RFA AA 19 005
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 19 070

Funding Number: PAR 19 070
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) Apply for PAR 19 071

Funding Number: PAR 19 071
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 18 057

Funding Number: RFA AI 18 057
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R21 Clinical Trial Optional) Apply for RFA MH 19 411

Funding Number: RFA MH 19 411
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R34 Clinical Trial Required) Apply for RFA MH 19 410

Funding Number: RFA MH 19 410
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R01 Clinical Trial Optional) Apply for RFA MH 19 412

Funding Number: RFA MH 19 412
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,999
Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed) Apply for PA 19 076

Funding Number: PA 19 076
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed) Apply for PA 19 081

Funding Number: PA 19 081
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 19 047", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: